Biotech

All Articles

Biogen's CEO said no high-risk sell 2023. He's ready to become bold

.While Biogen's pharma peers are seeking for late-stage resources with little bit of danger, CEO Chr...

Instil refills pipeline in $2B biobucks deal with ImmunOnco

.Instil Biography has actually been actually a biotech trying to find a pipeline after it scrapped i...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually returned liberties to a very early Alzheimer's disease course to Denali Therape...

Takeda taps brand-new mind of US oncology business-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of notable leadership hirings, shootings and ...

Vertex, hammered through AATD again, loses 2 resources on throw out stack

.Tip's try to treat an unusual genetic condition has hit an additional obstacle. The biotech threw 2...

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of staff

.Vir Biotechnology's second-quarter revenues file had not been except big headlines. The provider in...

Galapagos pauses CAR-T tissue therapy trial over Parkinsonism case

.Galapagos has actually paused application in a trial of a BCMA-directed CAR-T tissue therapy, pushi...

James Wilson leaving Penn to release 2 brand new biotechs

.After much more than thirty years, genetics treatment trailblazer James Wilson M.D., Ph.D., is actu...

3 biotechs attempt to beat the summer warm by shedding personnel

.As biotechs attempt to turn a fresh page in August, at the very least 3 companies have shed team in...

venBio elevates $528M for fifth life scientific researches VC fund

.Expert venture capital company venBio has actually elevated an additional half a billion dollars to...